Interleukin-33 acts as a transcriptional repressor and extracellular cytokine in fibroblast-like synoviocytes in patients with rheumatoid arthritis

Cytokine

Volumn 77, Issue , 2016, Pages 35-43

  Lee, Eun Ju ^a,c   So, Min Wook ^b   Hong, Seokchan ^c   Kim, Yong Gil ^c   Yoo, Bin ^c   Lee, Chang Keun ^c  

^a Asan Medical Center   (South Korea)

^b Pusan National University Yangsan Hospital   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

Author keywords

Fibroblast like synoviocytes; Interleukin 33; Osteoclastogenesis; Rheumatoid arthritis; Transcriptional repressor

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; BIOLOGICAL MARKER; CD14 ANTIGEN; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 33; MATRIX METALLOPROTEINASE; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; POLYINOSINIC POLYCYTIDYLIC ACID; RECEPTOR ANTIBODY; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; CXCL10 PROTEIN, HUMAN; TNFSF11 PROTEIN, HUMAN;

ADULT; ARTICLE; BONE EROSION; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST LIKE SYNOVIOCYTE; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MALE; NEGATIVE FEEDBACK; OSTEOARTHRITIS; OSTEOCLAST; OSTEOCLASTOGENESIS; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; WESTERN BLOTTING; AGED; BLOOD; BONE DEVELOPMENT; CELL CULTURE; DRUG EFFECTS; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; IMMUNOBLOTTING; METABOLISM; MIDDLE AGED; MONOCYTE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SYNOVIUM;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; CHEMOKINE CXCL10; COCULTURE TECHNIQUES; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOBLOTTING; INTERLEUKIN-33; MALE; MIDDLE AGED; MONOCYTES; NF-KAPPA B; OSTEOGENESIS; RANK LIGAND; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SYNOVIAL MEMBRANE; TRANSCRIPTION, GENETIC;

EID: 84946239843     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2015.10.005     Document Type: Article

References (32)

1. McInnes I.B., Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 2007, 7:429-442.
2. McInnes I.B., Schett G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 2011, 365:2205-2219.
3. Bartok B., Firestein G.S. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol. Rev. 2010, 233:233-255.
4. Onda H., Kasuya H., Takakura K., Hori T., Imaizumi T., Takeuchi T., et al. Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage. J. Cerebral Blood Flow and Metab.: Off. J. Int. Soc. Cerebral Blood Flow Metab. 1999, 19:1279-1288.
5. Baekkevold E.S., Roussigne M., Yamanaka T., Johansen F.E., Jahnsen F.L., Amalric F., et al. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am. J. Pathol. 2003, 163:69-79.
6. Pollheimer J., Bodin J., Sundnes O., Edelmann R.J., Skanland S.S., Sponheim J., et al. Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells. Arterioscler. Thromb. Vasc. Biol. 2013, 33:e47-e55.
7. Lopetuso L.R., Scaldaferri F., Pizarro T.T. Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis. Fibrogenesis Tissue Repair 2012, 5:18.
8. Kakkar R., Hei H., Dobner S., Lee R.T. Interleukin 33 as a mechanically responsive cytokine secreted by living cells. J. Biol. Chem. 2012, 287:6941-6948.
9. Sponheim J., Pollheimer J., Olsen T., Balogh J., Hammarstrom C., Loos T., et al. Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts. Am. J. Pathol. 2010, 177:2804-2815.
10. Palmer G., Talabot-Ayer D., Lamacchia C., Toy D., Seemayer C.A., Viatte S., et al. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis Rheum. 2009, 60:738-749.
11. Carriere V., Roussel L., Ortega N., Lacorre D.A., Americh L., Aguilar L., et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc. Natl. Acad. Sci. USA 2007, 104:282-287.
12. Roussel L., Erard M., Cayrol C., Girard J.P. Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket. EMBO Rep. 2008, 9:1006-1012.
13. Ali S., Mohs A., Thomas M., Klare J., Ross R., Schmitz M.L., et al. The dual function cytokine IL-33 interacts with the transcription factor NF-kappaB to dampen NF-kappaB-stimulated gene transcription. J. Immunol. 2011, 187:1609-1616.
14. Leung B.P., Xu D., Culshaw S., McInnes L.B., Liew F.Y. A novel therapy of murine collagen-induced arthritis with soluble T1/ST2. J. Immunol. 2004, 173:145-150.
15. Xu D., Jiang H.R., Kewin P., Li Y., Mu R., Fraser A.R., et al. IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc. Natl. Acad. Sci. USA 2008, 105:10913-10918.
16. Verri W.A., Souto F.O., Vieira S.M., Almeida S.C.L., Fukada S.Y., Xu D.M., et al. IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy. Ann. Rheum. Dis. 2010, 69:1697-1703.
17. Matsuyama Y., Okazaki H., Tamemoto H., Kimura H., Kamata Y., Nagatani K., et al. Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis. J. Rheumatol. 2010, 37:18-25.
18. Arnett F.C., Edworthy S.M., Bloch D.A., Mcshane D.J., Fries J.F., Cooper N.S., et al. The American-Rheumatism-Association 1987 revised criteria for the classification of rheumatoid-arthritis. Arthritis Rheum. 1988, 31:315-324.
19. Kunisch E., Chakilam S., Gandesiri M., Kinne R.W. IL-33 regulates TNF-alpha dependent effects in synovial fibroblasts. Int. J. Mol. Med. 2012, 29:530-540.
20. Ospelt C., Brentano F., Rengel Y., Stanczyk J., Kolling C., Tak P.P., et al. Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis toll-like receptor expression in early and longstanding arthritis. Arthritis Rheum. 2008, 58:3684-3692.
21. Brentano F., Schorr O., Gay R.E., Gay S., Kyburz D. RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via toll-like receptor 3. Arthritis Rheum. 2005, 52:2656-2665.
22. Talabot-Ayer D., McKee T., Gindre P., Bas S., Baeten D.L., Gabay C., et al. Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis. Joint Bone Spine: revue du rhumatisme 2012, 79:32-37.
23. Matsuyama Y., Okazaki H., Hoshino M., Onishi S., Kamata Y., Nagatani K., et al. Sustained elevation of interleukin-33 in sera and synovial fluids from patients with rheumatoid arthritis non-responsive to anti-tumor necrosis factor: possible association with persistent IL-1beta signaling and a poor clinical response. Rheumatol. Int. 2012, 32:1397-1401.
24. Ngoi S.M., St Rose M.C., Menoret A.M., Smith D.E., Tovey M.G., Adler A.J., et al. Presensitizing with a toll-like receptor 3 ligand impairs CD8 T-cell effector differentiation and IL-33 responsiveness. Proc. Natl. Acad. Sci. USA 2012, 109:10486-10491.
25. Carrion M., Juarranz Y., Perez-Garcia S., Jimeno R., Pablos J.L., Gomariz R.P., et al. RNA sensors in human osteoarthritis and rheumatoid arthritis synovial fibroblasts: immune regulation by vasoactive intestinal peptide. Arthritis Rheum. 2011, 63:1626-1636.
26. Pecaric-Petkovic T., Didichenko S.A., Kaempfer S., Spiegl N., Dahinden C.A. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood 2009, 113:1526-1534.
27. Kim K.W., Kim H.R., Park J.Y., Park J.S., Oh H.J., Woo Y.J., et al. Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts. Arthritis Rheum. 2012, 64:1015-1023.
28. Salomon I., Netzer N., Wildbaum G., Schif-Zuck S., Maor G., Karin N. Targeting the function of IFN-gamma-inducible protein 10 suppresses ongoing adjuvant arthritis. J. Immunol. 2002, 169:2685-2693.
29. Kwak H.B., Ha H., Kim H.N., Lee J.H., Kim H.S., Lee S., et al. Reciprocal cross-talk between RANKL and interferon-gamma-inducible protein 10 is responsible for bone-erosive experimental arthritis. Arthritis Rheum. 2008, 58:1332-1342.
30. Mun S.H., Ko N.Y., Kim H.S., Kim J.W., Kim do K., Kim A.R., et al. Interleukin-33 stimulates formation of functional osteoclasts from human CD14(+) monocytes. Cell. Mol. Life Sci. 2010, 67:3883-3892.
31. Hamada T., Torikai M., Kuwazuru A., Tanaka M., Horai N., Fukuda T., et al. Extracellular high mobility group box chromosomal protein 1 is a coupling factor for hypoxia and inflammation in arthritis. Arthritis Rheum. 2008, 58:2675-2685.
32. Hudson C.A., Christophi G.P., Gruber R.C., Wilmore J.R., Lawrence D.A., Massa P.T. Induction of IL-33 expression and activity in central nervous system glia. J. Leukoc. Biol. 2008, 84:631-643.